AMLX Amylyx Pharmaceuticals, Inc.
Healthcare$13.58-2.51%ClosedMarket Cap: $1.13B
As of 2026-05-25
Institutional Ownership Summary
Investors Holding
190
13F Shares
112,319,292
Ownership %
120.3%
New Positions
38
Increased Positions
110
Closed Positions
30
Reduced Positions
46
ETF Exposure
| ETF Symbol | ETF Name | Shares Held | Weight % |
|---|---|---|---|
| 395,413 | 1.72% | ||
| Direxion Daily Pharmaceutical & Medical Bull 3X ETF | 11,126 | 1.25% | |
| ALPS Medical Breakthroughs ETF | 89,983 | 1.00% | |
| Virtus Biotech Clinical Trials ETF | 20,815 | 0.81% | |
| Fidelity Disruptive Medicine ETF | 23,554 | 0.58% | |
| 233,280 | 0.31% | ||
| iShares U.S. Pharmaceuticals ETF | 233,280 | 0.31% | |
| iShares Micro-Cap ETF | 230,265 | 0.25% | |
| 230,265 | 0.25% | ||
| 162,757 | 0.16% | ||
| iShares Biotechnology ETF | 687,536 | 0.11% | |
| Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 43,269 | 0.07% | |
| 63,001 | 0.07% | ||
| iShares Russell 2000 Growth ETF | 573,250 | 0.06% | |
| JPMorgan BetaBuilders U.S. Small Cap Equity ETF | 31,018 | 0.06% | |
| 573,250 | 0.06% | ||
| Invesco RAFI US 1500 Small-Mid ETF | 106,503 | 0.05% | |
| iShares ESG Aware MSCI USA Small-Cap ETF | 79,644 | 0.05% | |
| 439,569 | 0.04% | ||
| iShares Morningstar Small-Cap Growth ETF | 24,726 | 0.04% |